BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25129516)

  • 1. Value of CMR for the differential diagnosis of cardiac masses.
    Pazos-López P; Pozo E; Siqueira ME; García-Lunar I; Cham M; Jacobi A; Macaluso F; Fuster V; Narula J; Sanz J
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):896-905. PubMed ID: 25129516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MRI diagnosis of cardiac myxomas: sequence evaluation and differential diagnosis].
    Sommer T; Vahlhaus C; Hofer U; von Smekal A; Wardelmann E; Bierhoff E; Pauleit D; Wilhelm K; Textor J; Schild H
    Rofo; 1999 Feb; 170(2):156-62. PubMed ID: 10101355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: an observational study.
    Caspar T; El Ghannudi S; Ohana M; Labani A; Lawson A; Ohlmann P; Morel O; De Mathelin M; Roy C; Gangi A; Germain P
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):551-559. PubMed ID: 27904982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of a Whole Cardiac Mass Using Dual-Energy Computed Tomography: Comparison with Conventional Computed Tomography and Magnetic Resonance Imaging.
    Hong YJ; Hur J; Han K; Im DJ; Suh YJ; Lee HJ; Kim YJ; Choi BW
    Sci Rep; 2018 Oct; 8(1):15334. PubMed ID: 30337716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients.
    Hong YJ; Hur J; Kim YJ; Lee HJ; Nam JE; Kim HY; Choe KO; Choi BW
    Int J Cardiovasc Imaging; 2011 Dec; 27 Suppl 1():89-95. PubMed ID: 22002687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre.
    Giusca S; Mereles D; Ochs A; Buss S; André F; Seitz S; Riffel J; Fortner P; Andrulis M; Schönland S; Katus HA; Korosoglou G
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):879-888. PubMed ID: 28138817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Cardiac Magnetic Resonance Imaging and Echocardiography in Evaluation of Cardiac and Paracardiac Masses.
    Patel R; Lim RP; Saric M; Nayar A; Babb J; Ettel M; Axel L; Srichai MB
    Am J Cardiol; 2016 Jan; 117(1):135-40. PubMed ID: 26552505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging.
    Kassi M; Polsani V; Schutt RC; Wong S; Nabi F; Reardon MJ; Shah DJ
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1912-1922.e2. PubMed ID: 30551963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac MRI: A Useful Tool for Differentiating Cardiac Thrombi from Tumors.
    Slonimsky E; Konen O; Di Segni E; Konen E; Goitein O
    Isr Med Assoc J; 2018 Aug; 20(8):472-475. PubMed ID: 30084570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.
    Weinsaft JW; Kim RJ; Ross M; Krauser D; Manoushagian S; LaBounty TM; Cham MD; Min JK; Healy K; Wang Y; Parker M; Roman MJ; Devereux RB
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):969-79. PubMed ID: 19679285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes.
    Mousavi N; Cheezum MK; Aghayev A; Padera R; Vita T; Steigner M; Hulten E; Bittencourt MS; Dorbala S; Di Carli MF; Kwong RY; Dunne R; Blankstein R
    J Am Heart Assoc; 2019 Jan; 8(1):e007829. PubMed ID: 30616453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours.
    Fussen S; De Boeck BW; Zellweger MJ; Bremerich J; Goetschalckx K; Zuber M; Buser PT
    Eur Heart J; 2011 Jun; 32(12):1551-60. PubMed ID: 21498848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.
    Chan AT; Plodkowski AJ; Pun SC; Lakhman Y; Halpenny DF; Kim J; Goldburg SR; Matasar MJ; Moskowitz CS; Gupta D; Steingart R; Weinsaft JW
    J Cardiovasc Magn Reson; 2017 Oct; 19(1):76. PubMed ID: 29025425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential and prognostic value of cardiovascular magnetic resonance derived scoring algorithm in cardiac tumors.
    Yue P; Xu Z; Wan K; Xie X; Ji S; Sun J; Chen Y
    Int J Cardiol; 2021 May; 331():281-288. PubMed ID: 33582195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses.
    Chan AT; Maya TR; Park C; Tak K; Liberman N; Jain RH; Park MJ; Park RY; Grizzard J; Kim G; Tap WD; Jessurun J; Liu J; Kim J; Steingart RM; Weinsaft JW
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):128-145. PubMed ID: 37410010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Feature Analysis Using Native T1 Mapping for Discriminating Between Cardiac Tumors and Thrombi.
    Son J; Hong YJ; Kim S; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
    Acad Radiol; 2022 Apr; 29 Suppl 4():S1-S8. PubMed ID: 33419643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of contrast perfusion echocardiography for differential diagnosis of cardiac masses.
    Tang QY; Guo LD; Wang WX; Zhou W; Liu YN; Liu HY; Li L; Deng YB
    Ultrasound Med Biol; 2015 Sep; 41(9):2382-90. PubMed ID: 26087885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of white and red thrombus with magnetic resonance imaging: a phantom study.
    Hu XY; Ge ZF; Zee CS; Gong XY
    Chin Med J (Engl); 2012 Jun; 125(11):1889-92. PubMed ID: 22884048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.